1kits(10Fiyɛliw) .
| A sɔrɔli: | |
|---|---|
| Hakɛ: | |
▎ Retatrutid ka ɲɛfɔli kunbaba
Retatrutid ye pepitiri fura kura ye. I n’a fɔ agoniste triple receptor, a bɛ baara kɛ glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) ani glucagon minɛbagaw kan waati kelen na. A bɛ mɔgɔ kelen-kelen bɛɛ dɛmɛ u ka girinya dɔgɔya a kɛtɔ ka dumuni nege labɛn cogo bɛɛ la, ka fasa bonya, ka kɔngɔ bali, ani ka fanga musaka caya.
Ka fara o kan, Retatrutid bɛ se ka dusukun ni farikoloɲɛnajɛ farati jiralan caman fana ɲɛ, i n’a fɔ tansiyɔn, ɛmoɲini sukaro, joli sukaro min bɛ sunɔgɔ, inisɔndiya, kolosinsinnan bɛɛ lajɛlen, kolosinsinnan minnu ka dɔgɔn, ani triglycérides. A bɛ nɔ ɲuman bila fana banabagatɔw la minnu ka sugunɛbilenni tɛ dɔlɔ ye, o bɛ kɛ sababu ye ka mɔgɔ fanba ka sugunɛ tulu hakɛ segin a cogo kɔrɔ la.
Ni aw ye a suma ni agoniste kelen walima fila ye, Retatrutid bɛ joli sukaro, farikolo girinya, a ɲɔgɔnnaw labɛn ka bɔ yɔrɔ caman na, a kɛtɔ ka GLP-1, GIP ani glucagon (GCG) minɛbaga saba baara waati kelen na. Hakilila la, a bɛ se ka farikoloɲɛnajɛ banaw ɲɛnabɔ ka ɲɛ kosɛbɛ, wa nafa kɛrɛnkɛrɛnnenw b’a la a fan dɔw la i n’a fɔ farikolo girinya dɔgɔyali, sugunɛbilenni dɔgɔyali, ani joli sukaro hakɛ jiginni.
Retatrutid minɛbaga caman ka baara kɛ ɲɔgɔn fɛ, o b’a to a bɛ se ka kɛ ka tɛmɛ GLP-1 minɛbaga agoniste walima dual receptor agoniste kɔrɔlenw kan farikoloɲɛnajɛ labɛnni na ani farikolo girinya kɔlɔsili la, o bɛ furakɛli suguya kura di banabagatɔw ma minnu fasalen don ani sukarodunbana suguya 2 bɛ minnu na.
▎ Retatrutid ka ɲininiw
Retatrutid ka ɲininiw kɛcogo ye mun ye?
Fasa kɛra foroba kɛnɛyako gɛlɛyabaw dɔ ye bi jamana kɔnɔ. A bɛ se ka kɛnɛya gɛlɛya caman lase mɔgɔ ma i n’a fɔ sukarodunbana suguya 2, dusukunnabana, tansiyɔn jiginni, jolidɛsɛ, ani sugunɛbilenni min tɛ dɔlɔ ye. Ni fasa hakɛ bɛ ka caya ka taa a fɛ, furakɛli kuraw mago bɛ teliya la ka taa a fɛ minnu bɛ se ka farikolo girinya kunbɛn ka ɲɛ ani ka kɛnɛyako ɲɛ Hali ni ɲɛnamaya kɛcogo fɛɛrɛw, i n’a fɔ farikoloɲɛnajɛ caya ani dumunikɛcogo, olu ye fɛɛrɛ jɔnjɔnw ye farikolo girinya kunbɛnni na, a ka gɛlɛn kosɛbɛ baliku fasa banabagatɔ caman ma ka u farikolo girinya dɔgɔyali kuntaalajan mara.
Retatrutid, i n’a fɔ agoniste sabatilen kura, o bɛ se ka baara kɛ glucagon ɲɔgɔnna pepitiri-1 minɛbaga kan (
GLP-1R), insulinotropic polypeptide receptor (GIPR) min bɛ tali kɛ sukaro la (GIPR), ani glucagon minɛbaga (GCGR). O baarakɛcogo min bɛ Kɛ ni jaabi caman ye, o bɛ nafa caman Di a ma farikolo girinya dɔgɔyali siratigɛ la. Ni aw ye a suma ni farikolojidɛsɛ furaw ye minnu bɛ baara kɛ furakisɛ kelen dɔrɔn de kan, Retatrutid bɛ se ka farikolo ka farikoloɲɛnajɛ kɛcogo ɲɛnabɔ ka ɲɛ [1] . Retatrutid bɛ mɔgɔ farikolo girinya dɔgɔya ni a bɛ ɔrimɔni caman minɛcogo ɲɛnabɔ, a tɛ nafa kabakoma jira dɔrɔn, nka a bɛ kɔnɔboli kɔlɔlɔ nɔgɔmanw fana sɔrɔ. Ka fara o kan, i n’a fɔ Retatrutid ye farikolojidɛsɛ fura ye min fanga ka bon kosɛbɛ ani a bɛ se ka kɛ jamanaden hakɛ caman ye ni a bɛ tali kɛ farikolojidɛsɛ fura kura wɛrɛw la.
Retatrutid ye mun ye?
Retatrutid ye pepitiri-1 (GLP-1) minɛbaga kura ye min bɛ baara kɛ waati jan kɔnɔ. A bɛ fɛn caman sɛmɛntiya ani ka ɲɛ ka da GLP-1 nafama sigicogo kan, wa a bɛ se ka siri kɛrɛnkɛrɛnnenya la GLP-1 minɛbaga la ani k’a baara, ka farikoloɲɛnajɛ baara kɛ i n’a fɔ GLP-1 nafama, i n’a fɔ ka inisɔndiya bɔli sabati, ka sukaro bɔli bali, ka kɔnɔbara lankolonya bila kɔfɛ, ka dumuni nege dɔgɔya, a ɲɔgɔnnaw A kɛcogo ka bon sukarodunbana furakɛli la ani ka girinya kunbɛn.
Retatrutid ka baarakɛcogo ye mun ye?
Retatrutid ka baarakɛcogo bɛ bɔ a ka agoniste nɔw la minnu bɛ sɔrɔ a minɛbaga caman kan. A fɔlɔ, a ka agoniste nɔ min bɛ sɔrɔ glucagon-like peptide-1 receptor (GLP-1R) la, o bɛ se ka dɔ fara insuline bɔli kan, ka glucagon bɔli bali, ka joli sukaro hakɛ dɔgɔya, ani o waati kelen na ka kɔnɔbara lankolonya bila kɔfɛ, ka dɔ fara fasa kan, ka dumuni dunta dɔgɔya Filanan, a ka agoniste nɔ min bɛ sɔrɔ insulinotropic polypeptide receptor (GIPR) la min bɛ tali kɛ sukaro la, o bɛ se ka insuline bɔli sabati, ka sukaro baaracogo ɲɛ, ani ka nɔ bila tulumafɛnw falenni na, ka tulumafɛnw bɔli bali ani ka tulumafɛnw sɔrɔli sabati Ka fara o kan, Retatrutid ka agoniste nɔ min bɛ glucagon receptor (GCGR) kan, a ka c’a la, o bɛ glycogenolyse ni gluconeogenesis sabati sugunɛ na, o bɛ dɔ fara joli sukaro hakɛ kan. Nka, Retatrutid ka baara fɛ, o sukaro wulicogo in bɛ bɔ a la ni a minɛbaga fila tɔw nɔ ye, ka sɔrɔ a bɛ tulumafɛnw bɔli sabati ani ka tulu dɔgɔya dalajɛli Nin wale kɛcogo min bɛ kɛ ni laɲini caman ye, o bɛ se ka kɛ sababu ye ka fasa furakɛ ka tɛmɛ farikolojidɛsɛ fura kelenw kan.
Ni Retatrutid ye nin farikolojɔlan saba ninnu baara waati kelen na, a bɛ se ka farikoloɲɛnajɛ kɛcogo caman kɛ ani ka furakɛli nɔw lase fasa ni banaw ma minnu bɛ tali kɛ o la. Joli sukaro hakɛ labɛnni siratigɛ la, ikomi GLP-1R ni GIPR baarakɛli bɛ inisɔndiya bɔli sabati ani ka sukaro bɔli bali, wa GCGR baarakɛli bɛ kunbɛn ni a minɛbaga fila tɔw nɔ ye, Retatrutid bɛ se ka joli sukaro hakɛ labɛn ka ɲɛ, o min nafa ka bon kosɛbɛ sukarodunbana suguya 2 furakɛli la [1 , Tumu dalajɛli dɔgɔyali siratigɛ la, GCGR baarakɛli bɛ tulumafɛnw bɔli sabati ani ka tulumafɛnw dalajɛli dɔgɔya, ka sɔrɔ GLP-1R baarakɛli bɛ dɔ fara fasa kan ani ka dumuni dunta dɔgɔya, o bɛ tulu sɔrɔli dɔgɔya ka taa fɛ a Ka fara o kan, Retatrutid fana bɛ nɔ ɲuman bila sugunɛbilenni na min tɛ dɔlɔ ye. A bɛ se ka tulu hakɛ dɔgɔya sugunɛ na ani ka sugunɛ baara ɲɛ.


HbA1c, farikolo girinya, tansiyɔn, ani tulumafɛnw Kunnafoni ye hakɛ fitininw ye (ni filiw ye minnu bɛ SEw jira) ka bɔ nafa sɛgɛsɛgɛli kulu la, fo ni a fɔra cogo wɛrɛ la.
Soso:PubMed [4] Ɲɛjirali dɔw.
Retatrutid b’a nɔw jira fan jumɛnw na?
Retatrutid bɛ nɔba jira a fan caman na
Kisɛya dɔgɔyali nɔba : Retatrutid ye farikolojidɛsɛ nɔba jira kɛnɛyaso sɛgɛsɛgɛli caman na. Misali la, kɛnɛyaso ka sɛgɛsɛgɛli dɔ la min kɛra baliku 338 kan (Jastreboff AMM, 2023), banabagatɔ minnu furakɛra ni Retatrutid hakɛ danfaralenw ye, olu girinya dɔgɔyara kosɛbɛ dɔgɔkun 48 kɔnɔ. Olu la, banabagatɔ minnu tun bɛ miligaramu 12 ta kulu la, olu farikolo girinya hakɛ dɔgɔyara 24,2%, wa banabagatɔ hakɛ caman ye girinya dɔgɔyali sɔrɔ hakɛ caman na. Misali la, banabagatɔ minnu ye miligaramu 4, miligaramu 8 ani miligaramu 12 ta, banabagatɔ 92%, 100% ani 100%, olu farikolo girinya dɔgɔyara 5% walima ka tɛmɛ o kan. Kalan wɛrɛ la [3] , sɛgɛsɛgɛli fila kɛra minnu kɛra ni mɔgɔ 353 ye minnu bɛ sukarodunbana suguya 2 la, olu y’a jira ko ni i ye a suma ni furakisɛ ta ye, Retatrutid bɛ se ka banabagatɔw farikolo girinya dɔgɔya kosɛbɛ ni kilogaramu 11,89 ye, ani ka dɔ bɔ ɛmoɲini glycété (HbA1C) fana na. Ka fara o kan, banabagatɔ balikuw ka kɔrɔbɔliw la, fasa bɛ minnu na ni sukarodunbana tɛ, Retatrutid ye banabagatɔw girinya dɔgɔya 24,2%, ani banabagatɔ 83% ye u farikolo girinya dɔgɔya 15% walima ka tɛmɛ o kan dɔgɔkun 48 kɔnɔ. Nin jaabi ninnu b’a jira ko Retatrutid bɛ se ka mɔgɔ farikolo girinya dɔgɔya.
Sukarodunbana suguya 2 furakɛli : Retatrutid fana bɛ se dɔw jira sukarodunbana suguya 2 furakɛli la. Kɛnɛyaso sɛgɛsɛgɛli dɔw la, Retatrutid y’a jira ko dɔ bɔra ɛmoɲini glycété (HbA1c) la ani ka kɛɲɛ ni a tata hakɛ ye. Misali la, sɛgɛsɛgɛli dɔ la, sukarodunbana suguya 2 bɛ banabagatɔ minnu na, Retatrutid ye joli sukaro kunbɛnni nɔba jira. Ni aw ye a suma ni furakisɛ ta ye, ɛmoɲini glycété (émoglobine glycé) dɔgɔyara ni 1,64% ye [3] . Ka fara o kan, sɛgɛsɛgɛli dɔ la min kɛra ni mɔgɔw ye, min kɛra ni mɔgɔ fila ye, min kɛra ni furakisɛ ye ani min kɛra ni baara ye, min kɛra ni kulu kelen ye, min kɛra ni jabɛti suguya 2 ye, baganw ka misali minnu bɛ ni sukarodunbana suguya 2 ye, Retatrutid furakɛli kɔfɛ, olu ye dɔ bɔ kosɛbɛ ɛmoɲini hakɛ la, wa u farikolo girinya fana dɔgɔyara cogo la min bɛ bɔ a tata la hakɛ O bɛ se ka kɛ fura in nɔ bɛɛ ye GLP-1, GCGR ani GIPR la, olu minnu bɛ sukaro sɛnɛcogo ni fanga balansi ɲɛ.
Dusukun ni jolisiraw ka faratiw ɲɛnabɔli : Retatrutid tɛ se ka farikolo girinya dɔgɔya dɔrɔn, nka a bɛ se ka dusukun ni jolisiraw faratiw fana ɲɛ, i n’a fɔ joli segin furakisɛw hakɛ ani joli segin furakisɛw hakɛ. O b’a jira ko jɛɲɔgɔnya gɛlɛn bɛ fasa ni dusukunnabana cɛ, wa Retatrutid bɛ se ka fasa banabagatɔw dusukun ni jolisiraw kɛnɛya sabati sira caman fɛ. Misali la, ni aw ye dɔ bɔ u hakɛ la minnu tɛ HDL-C, apoB ani LDLP ye, o bɛ se ka dɔ bɔ joli siraw la; ni jolisegindumuni sukaro hakɛ dɔgɔyali bɛ se ka joli sukaro hakɛ kunbɛnni ɲɛ sukarodunbanabagatɔw la, o la, dusukun ni jolisiraw gɛlɛyaw farati bɛ dɔgɔya [3, 5,.
Sugunɛbilenni min tɛ dɔlɔ ye (NAFLD) furakɛli : Retatrutid ye pepitiri agoniste sabatilen kura ye min bɛ glucagon minɛbaga (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), ani glucagon-like peptide-1 receptor (GLP-1R) laɲini. Kɔlɔsiliw y’a jira ko Retatrutid bɛ se ka sugunɛbilenni furakɛ min tɛ dɔlɔ ye. Kalan dɔ la, sɛgɛsɛgɛli dɔ kɛra dɔgɔkun 48 kɔnɔ, min kɛra ni mɔgɔw ye, minnu kɛra ni farikolojɔli baarakɛbaliya ye, ani sugunɛ tuluma hakɛ ye ≥10% ye. Jateminɛw y’a jira ko dɔgɔkun 24 kɔnɔ, sugunɛ tulu caman yeli ɲɔgɔn fɛ ka bɔ a daminɛ na, mɔgɔ minnu furakɛra ni Retatrutidi hakɛ danfaralenw ye (miligaramu 1, miligaramu 4, miligaramu 8, ani miligaramu 12) olu kɛra -42,9%, -57,0%, -81,4% ani -82,4% ye, k’a sɔrɔ furakisɛ kulu ta kɛra +0,3 ye % O b’a jira ko Retatrutid bɛ se ka furakɛli nɔba bila sugunɛbilenni na min tɛ dɔlɔ ye.
Kuncɛli la, i n’a fɔ agoniste triple receptor kura, Retatrutid bɛ sebaayaba jira fasa ni banaw furakɛli la minnu bɛ tali kɛ a la. A bɛ se ka hadamadenw ka farikoloɲɛnajɛ labɛn ka bɔ yɔrɔ caman na ni a bɛ sukaro minɛbaga, insulinotrope polipɛtidi minɛbaga min bɛ sukaro la, ani pepitiri-1 minɛbaga min bɛ sukaro bɔ, o baara, ka joli sukaro kunbɛnni ɲɛ, ka farikolo girinya dɔgɔya, ani ka tulumafɛnw sɛnɛcogo ɲɛnabɔ. Retatrutid bɔli ye furakɛli suguya kura lase banabagatɔw ma minnu fasalen don, sukarodunbana suguya 2 bɛ minnu na, a ɲɔgɔnnaw A jirala ko a bɛna dancɛw tigɛ laadala furaw la minnu bɛ mɔgɔ kelen-kelen agoniste agoniste, ka marifa barikama di walasa ka fasa ni farikoloɲɛnajɛ banaw gɛlɛyabaw ɲɛnabɔ minnu bɛ ka caya ka taa a fɛ, ka furakɛli siraw yiriwa ka taa a fɛ, ka banabagatɔw ka ɲɛnamaya kɛcogo ɲɛ, ka sigida furakɛli dɔgɔya doni doni.
A sɛbɛnbaga ko la
Fɛn minnu kofɔlen dòn san fɛ, olu bɛɛ ɲinini Kɛra, k’u Labɛn ani k’u Lajɛ Cocer Peptides fɛ.
Dɔnniya gafe sɛbɛnbaga
Rosenstock J ye dɔnnikɛla ye min fanga ka bon kosɛbɛ furakɛli siratigɛ la, a ni baaradaw bɛ baara kɛ ɲɔgɔn fɛ kosɛbɛ i n’a fɔ Texas Iniwɛrisite Saheli-Tilebin-yanfan dɔgɔtɔrɔso ani Texas Iniwɛrisite Dallas. A bɛ ɲininiw kɛ fana santiriw la i n’a fɔ Kanada VIGOR Center ani Veloc Clin Res Ctr Med City.
A ka ɲininiw bɛ tali kɛ kɔnɔbarako ni farikoloɲɛnajɛ, dusukun ni jolisiraw ni dusukunnakow la, furakɛlicogo la, ani furakɛli kɛcogo kɔrɔbɔli la, k’a sinsin sukarodunbana, fasa, ani furakɛli minnu bɛ tali kɛ o la ani furaw dilanni. J Rosenstock ye ɲɛtaa caman sɔrɔ kɛnɛyaso furakɛli la, a tɔgɔ dara ko ɲininikɛla min tɔgɔ bɔra kosɛbɛ k’a ta san 2017 la ka se san 2024. O b’a jira ko a ka baara ye nɔba bila a la ani ko a dɔnna kosɛbɛ. A ni ɲininikɛla caman ka jɛkafɔ sababu fɛ, a ye ɲinini jɔnjɔnw sɔrɔlenw baara ka ɲɛ ka kɛ kɛnɛyaso baarakɛcogo ye, ka farikoloɲɛnajɛ ni dusukunnabana banabagatɔw nafa ani ka furakɛli dɔnniya yiriwa. Rosenstock J tɔgɔ sɛbɛnnen bɛ citation (citation) ɲɛfɔli sɛbɛn kɔnɔ [4].
▎ Sɛbɛn minnu bɛ tali kɛ o la
[1] Kaur M, Misra S. Sɛgɛsɛgɛli fura dɔ seginnkanni retatrutide, o ye agoniste saba fura kura ye fasa furakɛli kama[J]. Erɔpu jamanaw ka furakɛli gafe, 2024,80(5):669-676.DOI:10.1007/s00228-024-03646-0.
[2] Jastreboff A. M., Kaplan L. M., Frias J. P., ani a ɲɔgɔnnaw. Triple-Hormone-Receptor Agonist Retatrutid ka ɲɛsin fasa ma - Fasa 2 sɛgɛsɛgɛli[J]. Angletɛri kura ka furakɛli gafe, 2023,389(6):514-526.DOI:10.1056/NEJMoa2301972.
[3] Lopez D. C., Pajimna J. T., Milan M. D., ani a ɲɔgɔnnaw. 7792 Retatrutid ka baarakɛcogo ɲuman farikolo girinya dɔgɔyali la ani a dusukun ni farikoloɲɛnajɛ nɔw balikuw la: Seginkanni sigilen ni a sɛgɛsɛgɛli[J]. Ɲɛnamaya kɛcogo ɲuman ka gafe, 2024,8(1):163-749.DOI:10.1210/jendso/bvae163.749.
[4] Rosenstock J, Frias J, Jastreboff A. M., ani mɔgɔ wɛrɛw. Retatrutid, GIP, GLP-1 ani glucagon receptor agoniste, sukarodunbana suguya 2 bɛ mɔgɔ minnu na: sɛgɛsɛgɛli min kɛra k’a sɔrɔ a ma kɛ cogo si la, min kɛra ni fiyentɔ fila ye, ni furakisɛ ye ani min bɛ kɛ ni wale ye, min bɛ kɛ ni kulu ye min bɛ taa ɲɔgɔn fɛ, fasa 2nan na, min kɛra USA[J Lancet, 2023,402(10401):529-544.DOI:10.1016/S0140-6736(23)01053-X, Bamako, Mali.
[5] Nicholls S, Pirro V, Lin Y, ani a ɲɔgɔnnaw. Triple-hormone receptor agonist retatrutide bɛ lipoprotéines ni apolipoprotéines cogoya ɲɛ kosɛbɛ mɔgɔ minnu ka fasa walima minnu girinya ka ca[J]. Erɔpu dusukunnakow gafe, 2024,45.DOI:10.1093/eurheartj/ehae666.1501.
[6] Ray A. Retatrutid: incretin minɛbaga saba bɛ fasa kunbɛnni na[J]. Sɛgɛsɛgɛli furaw kan dɔnnikɛlaw ka hakilina, 2023,32(11):1003-1008.DOI:10.1080/13543784.2023.2276754.
[7] Sanyal A. J., Kaplan L. M., Frias J. P., ani mɔgɔ wɛrɛw. Triple hormone receptor agonist retatrutide ka ɲɛsin farikolojɔli baarakɛbaliya ma sugunɛbana fɛ: a kɛra sɛgɛsɛgɛli kɛcogo la min kɛra fasa 2a kɔnɔ[J]. Sigida furakɛli, 2024,30(7):2037-2048.DOI:10.1038/s41591-024-03018-2.
BƐƐRƐ KUNNAFONIW NI FƐRƐW KUNNAFONIW BƐƐ MIN BƐ NI WEBSITE KAN NA, U BƐ KUNNAFONIW FƆLƆ DƆRƆN NI KALANSENW YE.
Fɛn minnu bɛ di nin siti in kan, olu dabɔra ɲininiw dɔrɔn kama in vitro. Sɛgɛsɛgɛli in vitro (latinkan na: *glasi kɔnɔ*, o kɔrɔ ye gilasi kɔnɔ) bɛ kɛ hadamaden farikolo kɔkan. Nin fura ninnu tɛ furaw ye, Ameriki ka dumuniko ni furako ɲɛmɔgɔso (FDA) ma sɔn u ma, wa u man kan ka kɛ ka furakɛli bana, bana walima bana si bali, k’a furakɛ, walima k’a furakɛ. A dagalen don kosɛbɛ sariya fɛ ka nin fɛn ninnu don hadamaden walima bagan farikolo la cogo o cogo.